Reason for request
Inclusion on list of products for hospital use.
Clinical Benefit
Substantial |
The actual benefit of ACTILYSE 2 mg is substantial.
|
Clinical Added Value
minor |
ACTILYSE 2 mg provides a minor improvement in actual benefit (IAB IV) in terms of efficacy in comparison with ACTOSOLV UROKINASE.
|
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
GbrnuvTEwBd8Rx13